Glucose B. Braun (Glucose Monohydrate)

Glucose B. Braun is employed in several clinical situations where rapid provision of carbohydrate calories or correction of low blood glucose is required.

• Treatment of hypoglycemia in patients unable to take oral glucose.
• Component of parenteral nutrition regimens to supply energy.
• Fluid and electrolyte replacement when combined with appropriate electrolytes.
• Dilution medium for intravenous drug admixtures that require a carbohydrate carrier.
• Support during perioperative fasting to maintain blood glucose levels.

Adverse reactions to Glucose B. Braun are generally related to the intravenous administration of a carbohydrate solution and may vary in frequency and severity.

Common

• Local irritation or pain at the infusion site.
• Mild hyperglycemia when large volumes are infused rapidly.
• Electrolyte shifts such as mild hyponatremia or hypokalemia.
• Nausea or vomiting associated with rapid infusion.

Serious

• Severe hyperglycemia leading to osmotic diuresis.
• Fluid overload causing pulmonary edema in susceptible patients.
• Allergic reactions ranging from urticaria to anaphylaxis.
• Hyperosmolar hyperglycemic state in patients with uncontrolled diabetes.

When using Glucose B. Braun, clinicians should assess patient-specific factors and monitor parameters to minimize potential complications.

• Verify blood glucose levels before and during infusion to avoid excessive hyperglycemia.
• Adjust infusion rate in patients with renal or cardiac insufficiency to prevent fluid overload.
• Use compatible electrolyte solutions and avoid mixing with incompatible drugs.
• Monitor serum electrolytes, especially sodium and potassium, during prolonged therapy.
• Consider alternative carbohydrate sources in patients with known glucose intolerance or severe diabetes.
• Ensure aseptic technique to reduce risk of catheter‑related infection.

Glucose B. Braun may interact with other intravenous agents or systemic medications, influencing glucose balance, electrolyte status, or solution compatibility.

Avoid

• Co‑administration with high‑dose insulin infusions without close glucose monitoring.
• Mixing with calcium‑containing solutions that can precipitate calcium gluconate.
• Simultaneous infusion of potassium chloride in concentrations exceeding recommended limits.

Use with caution

• Concurrent use of diuretics that may alter fluid and electrolyte balance.
• Administration alongside beta‑adrenergic agonists, which can increase glucose production.
• Use with nephrotoxic drugs in patients at risk for renal impairment.
• Combining with other hypertonic solutions; monitor osmolar load.